Please login to the form below

Not currently logged in
Email:
Password:

Creston Health rebrands under Health Unlimited banner

Agencies including Red Door and PAN will operate separately and together
Health Unlimited Creston

Creston Health has rebranded as Health Unlimited in a move that will see the UK-based marketing communication group's agencies work more closely together.  

The group said its new approach would give its clients access to a diverse and complementary range of integrated technology, brand and consultancy services.  

Health Unlimited's CEO Catherine Warne said: “We are a group of agencies who can work separately or collaboratively to solve our client's challenges.  

“We bring together experts in communications, digital, branding, insight, education and marketing to create competitive advantage for our clients unconstrained by traditional ways of marketing.”  

As part of the changes all of the Creston Health agencies will be renamed. Its UK businesses become Red Door Unlimited, PAN Unlimited, DJM Unlimited, Rock Unlimited, Liberation Unlimited, Loooped Unlimited and Walnut Unlimited.  

In the US its agencies will now be known as CooneyWaters Unlimited, Corkery Group Unlimited and Alembic Unlimited. However, Health Unlimited's international network Chemia will remain unchanged.  

Debra Jux, associate director, procurement – business unit lead at Astellas Pharma Europe, said Health Unlimited's new approach was one of the models her company was looking for in its agency partners.  

“On a practical level, having access to a range of expertise from one single legal framework agreement reduces complexity,” Jux added.

Article by
Dominic Tyer

18th November 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics